09-Jun-2014
A meeting entitled "Update in diabetes: new drugs, new technology, new models of care" was held by the Royal College of Physicians (London) on Thursday 5th June 2014.
This included the debate: "Sulfonylureas should not be used routinely as second line treatments for patients with Type 2 Diabetes"
For: Dr Robert Ryder, Sandwell and West Birmingham Hospitals NHS Trust
Against: Professor Rury Holman, University of Oxford
The motion was defeated.